Insider filing · RVMD
Alan B. Sandler
Chief Development Officer
profile →
Revolution Medicines, Inc.
RVMD · Healthcare · 77 filings in 24 months
ticker →
Alan B. Sandler sold $1.2M of Revolution Medicines (RVMD)
Executed Sep 29, disclosed Oct 1, 2 days later.
Value, as filed
$1.2M
6,008 sh across 4 lots
Executed
Sep 29
the trade date, as filed
Disclosed
Oct 1
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ASAlan B. Sandler (Chief Development Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Revolution Medicines, Inc. (RVMD). The largest single filing was $1.2M of RVMD (6,008 sh across 4 lots, as filed), executed Sep 29.
The name
RVMDHealthcare · Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→